Evidence map›Paper›PMID 41248874›Full record

ArticleAmerican journal of ophthalmology2026

The Developmental Landscape of Children With Uveal Coloboma and Its Relationship With Clinical Phenotype and Genetics.

Brian P Brooks, Alexandra T Hehn, Delphine Blain, Cristan Farmer, Lisa A Joseph, Edythe Wiggs, Laura Segalà, Bin Guan, Audrey Thurm, Ananya S Pathapadu

Abstract read
In one paragraph

Article in American journal of ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Brian P BrooksFrom the National Eye Institute (B.P.B., D.B., B.G., and A.S.P.), National Institutes of Health, Bethesda, Maryland, USA. Electronic address: brooksb@nei.nih.gov.
Alexandra T HehnNational Institute of Mental Health (A.T.H., C.F., L.A.J., and A.T.), National Institutes of Health, Bethesda, Maryland, USA.
Delphine BlainFrom the National Eye Institute (B.P.B., D.B., B.G., and A.S.P.), National Institutes of Health, Bethesda, Maryland, USA.
Cristan FarmerNational Institute of Mental Health (A.T.H., C.F., L.A.J., and A.T.), National Institutes of Health, Bethesda, Maryland, USA.
Lisa A JosephNational Institute of Mental Health (A.T.H., C.F., L.A.J., and A.T.), National Institutes of Health, Bethesda, Maryland, USA.
Edythe WiggsNational Institute of Neurological Disorders and Stroke (E.W.), National Institutes of Health, Bethesda, Maryland, USA.
Laura SegalàDepartment of Behavioral Health (L.S.), Walter Reed National Military Medical Center, Bethesda, Maryland, USA.
Bin GuanFrom the National Eye Institute (B.P.B., D.B., B.G., and A.S.P.), National Institutes of Health, Bethesda, Maryland, USA.
Audrey ThurmNational Institute of Mental Health (A.T.H., C.F., L.A.J., and A.T.), National Institutes of Health, Bethesda, Maryland, USA.
Ananya S PathapaduFrom the National Eye Institute (B.P.B., D.B., B.G., and A.S.P.), National Institutes of Health, Bethesda, Maryland, USA.

Funding

Inter- and Intra-Species Comparative SequencingZIBHG000196 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI THOMAS, JAMES · 2009 to 2025
$177.6M
The Genetics of Uveal ColobomaZIAEY000469 · NEI · NATIONAL EYE INSTITUTE · PI BROOKS, BRIAN · 2009 to 2025
$35.2M
Intramural NIH HHS ZIA EY000469Intramural NIH HHS ZIB HG000196
6 · The paper itself

Abstract

purposeUveal coloboma may be an isolated finding or present as part of a syndrome, informed by systemic testing. Genetic testing may elucidate an underlying cause of disease. The likelihood of developmental delay in children with coloboma has not been well-studied. We examined the rates of developmental delay in coloboma patients with syndromic vs nonsyndromic presentations and with positive and negative molecular diagnoses.

methodsSeventy patients with coloboma underwent a battery of systemic testing, molecular diagnosis, and cognitive and/or adaptive behavioral testing between 2009 and 2023. Patients with ≥2 abnormal systemic findings, excluding ocular or developmental delay, were classified as syndromic. The associations between delay and syndromic diagnosis or positive molecular testing were analyzed with logistic regression.

resultsThe mean age of participants was 3.97 years. Twenty-three patients were syndromic. Causative variants were identified in 13 cases. Individuals with a syndromic presentation had greater odds of having or reporting developmental delay than those with a nonsyndromic presentation (odds ratio [95% confidence interval] = 4.81 [1.67, 14.69], Z = 2.85, P = .004). A syndromic diagnosis also increased the likelihood of having a solved genetic diagnosis (odds ratio [95% confidence interval] = 6.91 [1.94, 28.89], Z = 2.86, P = .004).

conclusionsSystemic findings are common in patients presenting with isolated coloboma, underscoring the need for deep phenotyping. In our study, a molecular diagnosis was obtained in only a minority, implying undiscovered genetic or environmental factors. Those patients with ≥2 systemic findings were more likely to be developmentally delayed and to have a positive molecular diagnosis. NOTE: Publication of this article is sponsored by the American Ophthalmological Society.

Indexed as

ColobomaDevelopmental DisabilitiesUveal DiseasesAdolescentChildChild, PreschoolFemaleGenetic TestingHumansInfantMalePhenotypeRetrospective Studies

Identifiers

PMID41248874
PMCPMC12880558

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.